RESMED INC (RMD) Options Risk Score
Real-time risk analysis for RMD options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full RMD options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan RMD Now — Free →
Is it risky to sell options on RESMED INC (RMD) right now?
Over a 4-week expiry window, RESMED INC (RMD) scores 100 out of 100 for options catalyst risk (HIGH). What pushes it there: an upcoming earnings report, 12 recent news items, 2 active legal filings and 12 clinical-trial catalysts, all landing inside the 4-week window. A HIGH reading (70+) means RMD has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.
RMD shows an IV Rank of 80 — implied volatility is near the top of its own one-year range, so RMD options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 45%. IV Rank is the most useful figure for deciding whether to sell or buy premium on RMD.
RMD reports on 2026-08-06. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer